乳腺癌中乙醛脱氢酶1与上皮性钙黏蛋白、神经性钙黏蛋白关系的研究
被引量:3
摘要
乳腺癌干细胞是一类具有自我更新及多向分化潜能的原始细胞,在一定条件下可以分化成多种不同功能的细胞,从而影响乳腺癌的发生、发展、转移、耐药及复发等生物学行为[1]。上皮-间质转化(epithelial-mesenchymal transition, EMT)在乳腺癌浸润转移过程中起着重要作用。本实验应用免疫组织化学方法研究乳腺癌干细胞标志物乙醛脱氢酶1(ALDH1)蛋白与 EMT 标志蛋白上皮性钙黏蛋白(E-cadherin)、神经性钙黏蛋白(N-cadherin)在正常乳腺组织、乳腺癌、转移性淋巴组织中的表达情况,探讨乳腺癌干细胞与乳腺癌浸润转移的关系。
出处
《中国医药生物技术》
2014年第3期231-233,共3页
Chinese Medicinal Biotechnology
参考文献12
-
1Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature, 2000, 406(6797):747-752.
-
2周凌,虞佩,王建丰,宋科瑛,江爱芳,徐红,李克.乙醛脱氢酶1蛋白在乳腺癌中的表达及临床意义[J].肿瘤,2009,29(7):663-667. 被引量:21
-
3Mahler-Araujo B, Savage K, Parry S, et al. Reduction of E-eadherin expression is associated with non-lobular breast carcinomas of basal-like and triple negative phenotype. J Clin Pathol, 2008, 61(5): 615-620.
-
4Lascombe I, Clairotte A, Fauconnet S, et al. N-cadherin as a novel prognostic marker of progression in superficial urothelial tumors. Clin Cancer Res, 2006, 12(9):2780-2787.
-
5AI-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Nad Acad Sci U S A, 2003, 100(7):3983-3988.
-
6Ginestier C, Hur MH, Charafe-Jauffret E, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell, 2007, 1(5):555-567.
-
7Hay ED. The extracellular matrix in development and regeneration. An interview with Elizabeth D. Hay. Int J Dev Biol, 2004, 48(8-9): 687-694.
-
8Wheelock MJ, Shintani Y, Maeda M, et al. Cadherin switching. J Cell Sci, 2008, 121(Pt 6):727-735.
-
9Morel AP, Li6vre M, Thomas C, et al. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One, 2008 3(8):e2888.
-
10Mani SA, Guo W, Liao Mr, et al. The epithelial-mesenchymal transition generates ceils with properties of stem cells. Cell, 2008, 133(4):704-715.
二级参考文献23
-
1Wheelock MJ,Shintani Y,Maeda M,et al.Cadherin switching[J].J Cell Sci,2008,121(PT 6):727-735.
-
2AI-Hajj M,Wieha MS,Benito-Hernandez A,et al.Prospective identification of tumorigenic breast cancer cells[J].Proc Natl Acad Sci USA,2003,1009(7):3983-3988.
-
3Mani SA,Guo W,Liao MJ,et al.The epithelial-mesenchymal transition generates cells with properties of stem cells[J].Ce11,2008,133(4):704-715.
-
4Honeth G,Bendahl PO,Ringn é r M,et al.The CD44+/CD24-phenotype is enriched in basal-like breast tumors[J].Breast Cancer Res,2008,10(3):R53.
-
5Mahler-Araujo B,Savage K,Parry S,et al.Reduction of E-cadherin expression is associated with non-lobular breast carcinomas of basal-like and triple negative phenotype[J].J Clin Pathol,2008,61 (5):615-620.
-
6Lascombe I,Clairotte A,Fauconnet S,et al.N-cadherin as a novel prognostic marker of progression in superficial urothelialtumors[J].Clin Cancer Res,2006,12(9),2780-2787.
-
7Vincent-Salomon A,Thiery JP.Host microenvironment in breast cancer development:epithelial-mesenchymal transition in breast cancer development[J].Breast Cancer Res,2003,5(2):101-106.
-
8Hulit J,Suyama K,Chung S,et al.N-cadherin signaling potentiates mammary tumor metastasis via enhanced extracellular signal-regulated kinase activation[J].Cancer Res,2007,67(7):3106-3116.
-
9Kaur G,Carnelio S,Rao N,et al.Expression of E-cadherin in primary oral squamous cell carcinoma and metastatic lymph nodes:an immunohistochemical study[J].Indian J Dent Res,2009,20(1):71-76.
-
10Abraham BK,Fritz P,McClellan M,et al.Prevalence of CD44/CD24-/low ceils in breast cancer may not be associated with clinical outcome but may favor distant metastasis[J].Clin Cancer Res,2005,11(3):1154-1159.
共引文献37
-
1韩明利,吴诚义,王艺梦.乙醛脱氢酶1蛋白与乳腺癌[J].复旦学报(医学版),2010,37(6):747-749. 被引量:1
-
2林丽芬,韦伟.ALDH1与乳腺癌的相关性研究[J].罕少疾病杂志,2010,17(6):44-47.
-
3毛跟年,李鑫,瞿建波.乙醛脱氢酶及其医疗领域研究进展[J].天然产物研究与开发,2011,23(1):193-197. 被引量:5
-
4李亭,胡立强,齐海智,贺志军,吴建国.乙醛脱氢酶1在结肠癌组织中的表达及其临床意义[J].中国普通外科杂志,2011,20(3):269-272. 被引量:10
-
5万琪,王飞,陈亚丽,郑艾.乙醛脱氢酶1与肿瘤干细胞相关性研究[J].华西医学,2011,26(3):476-478. 被引量:3
-
6毕小恺,吴诚义,韩明利,蔡建英.乳腺癌中ALDH1的表达与其分子亚型及ABCG2的关系[J].中国普通外科杂志,2011,20(11):1225-1229. 被引量:10
-
7朱之坤,吴诚义.MMP-3在乳腺癌演变中的作用[J].中国普通外科杂志,2011,20(11):1247-1250.
-
8黄华,章建国,仇晓军.乙醛脱氢酶1在非小细胞肺癌中的表达及意义[J].山东医药,2011,51(49):41-42. 被引量:4
-
9郭崇勇,李克,周凌,柯卫锋,王建丰,王瑞涛,宋科瑛.长程多柔比星化疗富集乳腺肿瘤干细胞[J].肿瘤,2012,32(1):27-31. 被引量:8
-
10朱之坤,刘志容,吴诚义.MMP-3与乳腺癌上皮间质转化的关系及其意义[J].生命科学研究,2012,16(1):63-67. 被引量:4
同被引文献36
-
1代志军,高洁,王西京,苏宝山,康华峰,张淑群,管海涛,闵卫利.乳腺导管增生癌变过程中HIF-1α的表达变化及意义[J].中国肿瘤临床与康复,2007,14(1):20-22. 被引量:8
-
2Giuliano AE, Hawes D,' Ballman KV, et al. Association of occult metastases in sentinel lymph nodes and bone marrow. with sur;cival among women with early-stage invasive breast cancer [J]. JAMA, 2011, 306 (4): 385-393.
-
3Hyseni A, van der Groep P, van der Wall E, et al. Subcel- lular FIH-1 expression patterns in invasive breast cancer in re- lation to HIF- lct expression [J]. Cell Oncol (Dordr), 2011, 34 (6): 565-570.
-
4Goldhirsch A, Wood WC, Coates AS, et al. Strategies for subtypes'deahng with the diversity of breast cancer: high- lights of the St. gallen international expert consensus on the primary therapy of early breast cancer 2011[J]. Ann Oncol, 2011, 22 (8):.1736-1747.
-
5Guan Y, Reddy KR, Zhu Q, et al. G-rich Oligonucleotides inhibit HIF-lalpha and HIF-2alpha and block tumor growth [J]. MolTher, 2010, 18 (1): 188-197.
-
6Iwatsuk IM, Mimori K, Yokobori T, et al. Epithelial-mes- enchymal transition in cancer development and its clinical sig- nificance [J]. Cancer Sci, 2010, 101 (2): 293-299.
-
7Laughner E, Taghavi P, Chiles K, et al. HER2 (neu) sig- naling increases the rate of hypoxia- inducible 1 ct ( HIF - lalpha) synthesis: novel mechanism for HIF-1 mediated vascular endothelial growth factor expression [ J ]. Mol CellBiol, 2001, 21 (12): 3995-4004.
-
8Yamamoto Y, Lbusuki M, Okumura Y, et al. Hypoxia-in- dueible factor 1 alpha is closely linked to an aggressive pheno- type in breast cancer [J].Breast Cancer Res Treat, 2008, 110 (3) : 465-475.
-
9Mani SA, Guo W, Liao MJ, et al. The epithelial-mesenchy- mal transition generates cells with properties of stem cells[J]. Cell, 2008, 133 (4): 704-715.
-
10Yoo YG, Christensen J, Gu J, et al. HIF- let mediates tumor hypoxia to confer a perpetual mesenchymal phenotype for malignant progression [J]. Sci Signal, 2011, 4 (178) : pt4.
引证文献3
-
1袁媛,张赟,高宇哲,童英,文安智,官志忠,曹颖.HIF-1α及EMT在不同分子亚型乳腺浸润性导管癌中的表达及意义[J].中国妇幼保健,2015,30(29):5054-5058. 被引量:2
-
2杨明月,马红艳,李秀清,徐延森,王平,鞠英博,孙杰.乳腺癌组织中ALDH1、CD133的表达及与肿瘤血管生成的关系[J].实用预防医学,2018,25(5):621-624. 被引量:3
-
3梁法清,杜正贵,何阳君.乳腺癌组织中ALDH1及BCRP的表达状况与乳腺癌病理特征的相关性分析[J].中国医药导报,2018,15(14):76-79. 被引量:4
二级引证文献9
-
1孙吉瑞,周炳娟,陈红,马秋双,张金库,孙哲,张东晨.HIF-1α和CA9在乳腺癌中的表达及其与基底细胞样型乳腺癌的关系[J].国际肿瘤学杂志,2017,44(6):415-419. 被引量:4
-
2赵文明,周炳娟,李金梅,陈雪,张金库.HIF-1α Glut-1表达与乳腺癌分化程度及分子亚型的关系[J].河北医学,2018,24(3):353-357. 被引量:7
-
3张辉,李果,刘扬帆,宋菲,张祎.217例乳腺癌患者配偶的压力及生活质量调查[J].实用预防医学,2019,26(4):484-486. 被引量:10
-
4刘庆伟.老年女性乳腺癌临床病理特征、治疗方式及预后的临床研究[J].牡丹江医学院学报,2019,40(3):70-73. 被引量:3
-
5周蓓,王婧,吴忠.BCRP与ki67在乳腺癌组织的表达及病理特征分析[J].中国处方药,2019,17(8):12-14. 被引量:4
-
6王波,董小林.AGGF1在乳腺癌中的表达与预后的关系[J].临床与病理杂志,2019,39(12):2685-2691.
-
7訾聪娜,樊娟,李艳明,李福龙,马先,邢珍.术前口服补液溶液对乳腺癌根治术患者术后康复进程及预后的影响[J].中国医药导报,2019,16(34):112-116. 被引量:5
-
8黄冬玲,刘奕仕,黄雪韵,梁玉玲,杜婉燕.2015—2017年东莞市石碣镇乳腺癌筛查率及影响因素分析[J].实用预防医学,2021,28(1):77-80. 被引量:9
-
9谢文,汪珺莉,夏菲.乳腺癌超声征象与p120ctn及CD133表达的相关性[J].安徽医学,2023,44(2):181-184. 被引量:4
-
1曾会会,郑荣生.BCRP在浸润性乳腺癌中的表达及其与上皮间质转化相关蛋白的相关性[J].蚌埠医学院学报,2016,41(11):1435-1439. 被引量:3
-
2洪坚善,彭浩,段小娴.E-cadherin的表达与肝细胞癌侵袭和转移的关系[J].基础医学与临床,2005,25(12):1139-1142. 被引量:3
-
3窦焕芝,卢萌.胃癌患者手术治疗前后血清E-CAD、CEA和CA72-4检测的临床应用[J].放射免疫学杂志,2013,26(1):49-50. 被引量:1
-
4张焕明.奥沙利铂联合氟尿嘧啶/亚叶酸钙治疗晚期胃癌临床疗效观察[J].现代肿瘤医学,2006,14(12):1575-1576.
-
5温川松,仝进毅.神经性生长因子及其受体在卵巢上皮性恶性肿瘤组织中的作用研究进展[J].中华全科医学,2016,14(7):1202-1205. 被引量:2
-
6黄普文,王榕生,卢凯华,穆庆霞,王建,刘凌翔,束永前.奥沙利铂联合氟尿嘧啶与醛氢叶酸治疗42例进展期胃癌的近期疗效观察[J].肿瘤防治杂志,2004,11(10):1091-1092. 被引量:8
-
7洪坚善,彭浩,段小娴,曹骥,欧超,杨华伟.E-Cadherin表达与肝细胞癌侵袭、转移的关系[J].广西医科大学学报,2006,23(5):699-702. 被引量:1
-
8黄勇,张华东,李宏伟,胡海霞,熊正文.Twist蛋白上皮性钙黏蛋白mRNA及蛋白在喉鳞癌中表达的研究[J].山西医药杂志(上半月),2011,40(5):447-449. 被引量:4
-
9陈晚平,易继林,李兴睿,刘谨文,孙华朋,沈文状,蒋进发,刘恩宇.肝细胞性肝癌中E-cadherin和nm23-h1的表达与转移的关系[J].临床外科杂志,2004,12(11):673-675. 被引量:8
-
10查之燕.卵巢癌患者手术前后血清IGF-Ⅰ、E-cad及VEGF水平的变化[J].放射免疫学杂志,2007,20(5):396-398. 被引量:13